Investigational Alzheimer's drug improves biomarkers of the disease
by Washington University School of MedicineRandall Bateman, MD, director of the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), an ongoing international clinical trial to evaluate e
Updated on: April 16,2024
11
Investigational Alzheimer's drug improves biomarkers of the disease
by Washington University School of MedicineRandall Bateman, MD, director of the Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), an ongoing international clinical trial to evaluate e
Updated on:April 16,2024
11